NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Up 16,375.0% in March

NovAccess Global Inc. (OTCMKTS:XSNX) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 65,900 shares, an increase of 16,375.0% from the March 15th total of 400 shares. Based on an average daily trading volume, of 621,800 shares, the short-interest ratio is currently 0.1 days.

NovAccess Global Price Performance

XSNX stock opened at $0.01 on Thursday. The company has a market cap of $349,800.00, a price-to-earnings ratio of -0.11 and a beta of 1.51. The business has a fifty day simple moving average of $0.02 and a 200-day simple moving average of $0.03. NovAccess Global has a 52 week low of $0.01 and a 52 week high of $0.22.

NovAccess Global (OTCMKTS:XSNX) last announced its quarterly earnings results on Tuesday, February 27th. The company reported $0.01 earnings per share (EPS) for the quarter.

NovAccess Global Company Profile

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.